Literature DB >> 8668683

Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption.

Y Li1, A K Mitra.   

Abstract

PURPOSE: Non drug loaded lipid vesicles have been investigated as promoters of pulmonary insulin absorption.
METHODS: Physical mixtures of liposomes with insulin were delivered intratracheally to rats by direct instillation method at an insulin dose level of 1 U/kg.
RESULTS: The overall hypoglycemic response, represented by area above the curve (AAC), correlated linearly with the lipid concentration for both the neutral and charged liposome-insulin preparations. The strongest response was observed with the positively charged liposomes followed by negatively charged and neutral liposome-insulin mixtures. Further toxicological studies indicated that charge-inducing agents, i.e., stearylamine and dicetylphosphate, can cause apparent disruption of pulmonary epithelial cells. From the difference of overall hypoglycemic response (AAC) among various formulations, it appears that the stronger hypoglycemic effect following positively charged liposome-insulin mixture is due to the membrane destabilizing effect on stearylamine. Optimum hypoglycemic effect was observed with a medium acyl-chain lipid (C10). The cumulative hypoglycemic response appeared to correlate inversely with the acyl carbon number of the phospholipid component from C10 to C18. The overall hypoglycemic effect does not appear to change within the liposomal size range of 0.1 micron - 1.98 microns, indicating that insulin absorption following intratracheal instillation is independent of the vesicle size within the range studied.
CONCLUSIONS: Phospholipid promoted insulin pulmonary absorption is significantly dependent on the concentration, charge and acyl chain length of the phospholipids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668683     DOI: 10.1023/a:1016029317299

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Peptides are better absorbed from the lung than the gut in the rat.

Authors:  J L Hoover; B D Rush; K F Wilkinson; J S Day; P S Burton; T J Vidmar; M J Ruwart
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

Review 2.  Structural basis for some permeability properties of the air--blood barrier.

Authors:  E E Schneeberger
Journal:  Fed Proc       Date:  1978-09

3.  Diffusion of univalent ions across the lamellae of swollen phospholipids.

Authors:  A D Bangham; M M Standish; J C Watkins
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

4.  Pulmonary delivery of free and liposomal insulin.

Authors:  F Y Liu; Z Shao; D O Kildsig; A K Mitra
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

5.  Binding of insulin to the external surface of liposomes. Effect of surface curvature, temperature, and lipid composition.

Authors:  J H Wiessner; K J Hwang
Journal:  Biochim Biophys Acta       Date:  1982-08-12

6.  Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration.

Authors:  K Hirano; C A Hunt
Journal:  J Pharm Sci       Date:  1985-09       Impact factor: 3.534

7.  Liposome toxicity in the mouse central nervous system.

Authors:  D H Adams; G Joyce; V J Richardson; B E Ryman; H M Wiśniewski
Journal:  J Neurol Sci       Date:  1977-03       Impact factor: 3.181

  7 in total
  6 in total

Review 1.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

2.  Improvement of dissolution and hypoglycemic efficacy of glimepiride by different carriers.

Authors:  Elham A Mohamed; Mahasen M Meshali; Abdel Monem M Foda; Thanaa M Borg
Journal:  AAPS PharmSciTech       Date:  2012-07-28       Impact factor: 3.246

Review 3.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

Review 4.  The lung as a route for systemic delivery of therapeutic proteins and peptides.

Authors:  R U Agu; M I Ugwoke; M Armand; R Kinget; N Verbeke
Journal:  Respir Res       Date:  2001-04-12

5.  Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics.

Authors:  Brian D Green; Stewart F Graham; Elaine Cowan; Praveen Kumar; Kerry J Burch; David J Grieve
Journal:  Metabolomics       Date:  2016-07-05       Impact factor: 4.290

6.  Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet.

Authors:  Miso Nam; Myung-Sook Choi; Sunhee Jung; Youngae Jung; Ji-Young Choi; Do Hyun Ryu; Geum-Sook Hwang
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.